öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

µ¼Ê¦ÐÕÃû£ºÓÚÏþºì
ÐÔ±ð£ºÅ®
ÈËÆøÖ¸Êý£º181

ËùÊôԺУ£º´óÁ¬Ò½¿Æ´óѧ
ËùÊôԺϵ£ºµÚÒ»ÁÙ´²Ñ§Ôº
Ö°³Æ£º¸±½ÌÊÚ
µ¼Ê¦ÀàÐÍ£º
ÕÐÉúöλÔÓéÀֵǼÈë¿ÚÏÂÔØ£ºÄÚ¿Æѧ£¨ÐÄѪ¹Ü£©
Ñо¿ÁìÓò£º 1£©¹ÚÐIJ¡¼°ÐÄ·¿²ü¶¯µÄÁÙ´²ÕïÖμ°·¢²¡»úÖƵÄÑо¿£»2£©»ºÂýÐÔÐÄÂÉʧ³£µÄÆð²«ÖÎÁÆ
Ñо¿ÁìÓò£º 1£©¹ÚÐIJ¡¼°ÐÄ·¿²ü¶¯µÄÁÙ´²ÕïÖμ°·¢²¡»úÖƵÄÑо¿£»2£©»ºÂýÐÔÐÄÂÉʧ³£µÄÆð²«ÖÎÁÆ [ÊÕÆð]




ͨѶ·½Ê½ :
µç×ÓÓʼþ£ºyuxiaohong0707@163.com


¸öÈ˼òÊö :
ÓÚÏþºì£¬Å®£¬Ò½Ñ§²©Ê¿£¬¸±Ö÷ÈÎҽʦ£¬¸±½ÌÊÚ

¿ÆÑй¤×÷ :
ÔÚÑÐÏîÄ¿£º
(1) ¡¶ÃâÒßµ°°×øÌå¦Â5i ͨ¹ýµ÷½ÚÏßÁ£Ì幦Äܱ£»¤Ðļ¡È±Ñª/ÔÙ¹à×¢ËðÉ˵ķÖ×Ó»úÖÆÑо¿¡·£¬¹ú¼Ò×ÔÈ»¿Æѧ»ù½ðÇàÄê»ù½ð£¬2016.1.1-2018.12.31,18ÍòÔª£¬Ö÷³Ö¡£(2) ¡¶XÏßÐÞ¸´½»²æ»¥²¹»ùÒò1£¨XRCC1£©±£»¤ÐÄÔàȱѪÔÙ¹à×¢ËðÉ˵ķÖ×Ó»úÖÆÑо¿¡·£¬ÁÉÄþÊ¡½ÌÓýÌü¿ÆѧÑо¿Ò»°ãÏîÄ¿£¬2015.1.1-2017.12.31,3ÍòÔª£¬Ö÷³Ö¡£(3) ¡¶Cystatin C ÔÚÎȶ¨Ò×Ëð¶¯ÂöÖàÑùÓ²»¯°ß¿éÖеÄ×÷Óü°»úÖÆÑо¿¡·£¬ÁÉÄþÊ¡¿Æѧ¼¼Êõ¼Æ»®ÏîÄ¿£¨ÁÉÄþÊ¡¿Æ¼¼Ìü£©£¬2014.1.1-2016.12.31,5ÍòÔª£¬Ö÷³Ö¡£(4) ¡¶ÃâÒßµ°°×øÌå¦Â5iÔÚÐļ¡È±Ñª/ÔÙ¹à×¢ËðÉËÖеÄ×÷Óü°·Ö×Ó»úÖÆ¡·£¬Ôº¿Æ¼¼Ó¢²Å¼Æ»®£¬2015.1.1-2017.12.31,30ÍòÔª£¬Ö÷³Ö¡£
´ú±íÎÄÕ£º
(1) Activationof NOD1 by DAP contributes to myocardial ischemia/reperfusion injuryvia multiple signaling pathways. Apoptosis, 2015, 20(4): 512-22, (IF=3.614), ͨѶ×÷Õß.(2) Aninteractive association of advanced glycation end-product receptor gene fourcommon polymorphisms with coronary artery disease in northeastern Han Chinese. PLoS One, 2013, 8(10):e76966, (IF=3.534), µÚÒ»×÷Õß.(3) Synergistic association of DNA repair relevant genepolymorphisms with the risk of coronary artery disease in northeastern HanChinese. Thromb Res, 2014, 133(2): 229-34, (IF=2.427) , µÚÒ»×÷Õß.(4) ¦Á-ÓñÃ׳àù´¼¶ÔÖ×Áö»µËÀÒò×Ó¦ÁÓÕµ¼µÄÈËÄÚƤϸ°ûHO-1»ùÒò±í´ï¼°°û½¬ÓÎÀë¸ÆˮƽµÄÓ°Ïì.ÖлªÒ½Ñ§ÔÓÖ¾,2009,89 (46): 3280-4, µÚÒ»×÷Õß.(5) ¦Á-ÓñÃ׳àù´¼¶ÔÖ×Áö»µËÀÒò×Ó¦ÁÓÕµ¼µÄÈËÄÚƤϸ°û»îÐÔÑõ²úÉú¼°Æ伤»îÐźÅͨ·µÄÓ°Ïì.ÖлªÒ½Ñ§ÔÓÖ¾,2009,89(4):266-70, µÚÒ»×÷Õß.(6) ÒøÐÓÄÚõ¥B¶ÔTNF¨»ÓÕµ¼µÄÈËÄÚƤϸ°û»îÐÔÑõ²úÉúµÄÓ°Ïì¼°Æä»úÖÆ,´óÁ¬Ò½¿Æ´óѧѧ±¨,2013,35(4):320-4, µÚÒ»×÷Õß.(7) Kearns-sayre×ÛºÏÕ÷²¢ÍêÈ«ÐÔ·¿ÊÒ´«µ¼×èÖͶþÀý.ÖлªÁÙ´²Ò½Ê¦ÔÓÖ¾,2011, 5(3):207-8, µÚÒ»×÷Õß.(8) ·çʪÐÔÐÄÔà°êĤÖû»Êõºó²¢ÐÄ·¿²ü¶¯¼Ì·¢·´¸´¼±ÐÔ¹Ú×´¶¯Âö˨ÈûÐÔÐļ¡¹£ËÀ1 Àý.ÖйúÐÄѪ¹ÜÔÓÖ¾,2012,17(1):68-9, µÚÒ»×÷Õß.